KRT18 and obesity disorder: Based on the study of 151 subjects with excess body weight, without clinical symptoms or laboratory markers of metabolic diseases, we can conclude that the plasma CK-18 M30 cut-off point at 150 U/L allows to distinguish between two metabolic phenotypes in obesity.